IBU- IVA Product Owner

Bengaluru, Karnataka, India

Apply with AI Apply

Not SpecifiedCompensation

Mid-level (3 to 4 years)Experience Level

Full TimeJob Type

UnknownVisa

PharmaceuticalIndustries

Requirements

Candidates should possess a Bachelor's degree and demonstrate at least 3 years of experience in Product Ownership or Product Management, with a strong understanding of Agile methodologies and software development lifecycles. Experience within the pharmaceutical industry, specifically with Medical, Marketing, and Value & Access capabilities, is highly desirable.

Responsibilities

As the IBU IVA Product Owner, you will define and communicate the product vision and strategy, ensuring alignment with business goals and long-term value delivery. You will oversee end-to-end Product Backlog management, collaborate with the team to realize backlog items, finalise product increments, and organise effective product releases. Furthermore, you will coordinate with IT and business stakeholders to shape the product vision and roadmap, and lead Product Discovery initiatives to validate problems and identify opportunities.

Skills

Product Ownership

Product Management

Agile Methodologies

Software Development Lifecycles

Product Backlog Management

Stakeholder Management

Product Vision

Roadmap Planning

Product Discovery

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters

1876Year Founded

$1,180.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.

Potential construction delays in Indiana could affect GLP-1 drug production timelines.

Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.

Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.

FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.

Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.

Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI

Try Jobo Free